Prediction of Treatment Week Eight Response & Sustained Virologic Response in Patients Treated with Boceprevir Plus Peginterferon Alfa and Ribavirin

Open Access

Peer-reviewed

Research Article

Alex Thompson ,

¶These authors are joint senior authors on this work.

Affiliation Department of Gastroenterology, St. Vincent's Hospital, Melbourne, VIC, Australia
⨯
Scott Devine ,

* E-mail: scott.devine@gmail.com

¶These authors are joint senior authors on this work.

Affiliation Merck, Whitehouse Station, New Jersey, United States of America
⨯
Mike Kattan,

Affiliation Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, United States of America
⨯
Andrew Muir

Affiliation Duke University School of Medicine, Durham, North Carolina, United States of America
⨯

Reader Comments (0)

Protease inhibitor therapy
Is the Subject Area "Protease inhibitor therapy" applicable to this article?

Thanks for your feedback.
Dose prediction methods
Is the Subject Area "Dose prediction methods" applicable to this article?

Thanks for your feedback.
Forecasting
Is the Subject Area "Forecasting" applicable to this article?

Thanks for your feedback.
Decision trees
Is the Subject Area "Decision trees" applicable to this article?

Thanks for your feedback.
Anemia
Is the Subject Area "Anemia" applicable to this article?

Thanks for your feedback.
Platelets
Is the Subject Area "Platelets" applicable to this article?

Thanks for your feedback.
Hepatitis C virus
Is the Subject Area "Hepatitis C virus" applicable to this article?

Thanks for your feedback.
Statins
Is the Subject Area "Statins" applicable to this article?

Thanks for your feedback.